Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of TCHL (Docetaxel, Carboplatin, Trastuzumab, Lapatinib) in Early Breast Cancer
NCT00820872Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by Cancer and Leukemia Group B. Started Feb 2009; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00820872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00820872.